Prognostic value and the changes of plasma levels of secretory type II phospholipase A2 in patients with coronary artery disease undergoing percutaneous coronary intervention
Author:
- P LiuPLP Liu
- 1 October 2003
- journal article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 24 (20) , 1824-1832
Abstract
To evaluate the serial changes of plasma secretory type II phospholipase A(2)(sPLA(2)), C-reactive protein (CRP) and cardiac injury markers in coronary artery disease (CAD) patients undergoing percutaneous coronary intervention (PCI) and their prognostic impacts. Plasma levels of sPLA(2), CRP, creatine kinase (CK), CK-MB and troponin-T were measured in 247 consecutive CAD patients receiving PCI procedure and 100 control subjects without CAD. In CAD group, serial blood samples were taken before coronary angiography, after coronary angiography, immediately after PCI, 24-h and 48-h after PCI. The sPLA(2)and CRP levels did not change after coronary angiography. The level of sPLA(2)significantly increased immediately after PCI. Creatine kinase and cardiac injury markers did not rise immediately after PCI, but elevated significantly at 24h after intervention. After a 2-year follow up, increased sPLA(2)(>450 ng/dl) after PCI, smoking and diabetes mellitus were the independent risk factors for subsequent coronary events (odds ratios 2.1, 2.3 and 3.1, respectively) in patients with CAD. The present study showed that PCI might cause immediate elevation of circulating levels of sPLA(2)following the mechanical disruption of coronary plaque, and the elevated level of sPLA(2)had significant prognostic impact.Keywords
This publication has 20 references indexed in Scilit:
- Effect of atorvastatin on endothelium-dependent vasodilation in patients with coronary artery diseaseThe American Journal of Cardiology, 2003
- Cooperation between secretory phospholipase A2 and TNF-receptor superfamily signaling. Implications for the inflammatory response in atherogenesisClínica e Investigación en Arteriosclerosis, 2003
- Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectorisThe American Journal of Cardiology, 2000
- Phospholipase A2 Modification of Low Density Lipoproteins Forms Small High Density Particles with Increased Affinity for Proteoglycans and GlycosaminoglycansJournal of Biological Chemistry, 1999
- Oxidized Lipids in Atherogenesis: Formation, Destruction and ActionThrombosis and Haemostasis, 1997
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Secretory group II phospholipase A2 in human atherosclerotic plaquesAtherosclerosis, 1995
- Diversity of group types, regulation, and function of phospholipase A2.Journal of Biological Chemistry, 1994
- Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cellsFEBS Letters, 1990
- Influence of Nicotine and Cotinine on the Expression of Plasminogen Activator Activity in Bovine Aortic Endothelial CellsThrombosis and Haemostasis, 1989